# Trial of Mesalamine for the Treatment of Active Microscopic Colitis

> **NCT00952952** · PHASE2,PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 70 (actual)

## Conditions studied

- Microscopic Colitis
- Diarrhea

## Interventions

- **DRUG:** Mesalamine

## Key facts

- **NCT ID:** NCT00952952
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2011-05-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00952952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00952952, "Trial of Mesalamine for the Treatment of Active Microscopic Colitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00952952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*